ProShare Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Buy |
39,156
+136
| +0.3% | +$5.87K | ﹤0.01% | 705 |
|
|
2025
Q1 | $1.35M | Sell |
39,020
-9,519
| -20% | -$329K | ﹤0.01% | 742 |
|
|
2024
Q4 | $1.33M | Buy |
48,539
+10,864
| +29% | +$298K | ﹤0.01% | 811 |
|
|
2024
Q3 | $959K | Buy |
37,675
+10,498
| +39% | +$267K | ﹤0.01% | 826 |
|
|
2024
Q2 | $688K | Sell |
27,177
-6,104
| -18% | -$155K | ﹤0.01% | 840 |
|
|
2024
Q1 | $1.03M | Buy |
33,281
+3,209
| +11% | +$99.2K | ﹤0.01% | 780 |
|
|
2023
Q4 | $1.21M | Buy |
30,072
+4,569
| +18% | +$184K | ﹤0.01% | 724 |
|
|
2023
Q3 | $673K | Buy |
25,503
+223
| +0.9% | +$5.88K | ﹤0.01% | 805 |
|
|
2023
Q2 | $435K | Buy |
25,280
+2,324
| +10% | +$40K | ﹤0.01% | 1033 |
|
|
2023
Q1 | $381K | Sell |
22,956
-3,030
| -12% | -$50.2K | ﹤0.01% | 1065 |
|
|
2022
Q4 | $198K | Buy |
25,986
+1,985
| +8% | +$15.1K | ﹤0.01% | 1506 |
|
|
2022
Q3 | $239K | Sell |
24,001
-1,019
| -4% | -$10.1K | ﹤0.01% | 1287 |
|
|
2022
Q2 | $227K | Sell |
25,020
-12,617
| -34% | -$114K | ﹤0.01% | 1394 |
|
|
2022
Q1 | $381K | Sell |
37,637
-8,968
| -19% | -$90.8K | ﹤0.01% | 1467 |
|
|
2021
Q4 | $778K | Sell |
46,605
-1,766
| -4% | -$29.5K | ﹤0.01% | 1183 |
|
|
2021
Q3 | $2.27M | Sell |
48,371
-6,373
| -12% | -$299K | 0.01% | 691 |
|
|
2021
Q2 | $3.34M | Buy |
54,744
+8,822
| +19% | +$538K | 0.01% | 592 |
|
|
2021
Q1 | $2.83M | Buy |
45,922
+10,872
| +31% | +$670K | 0.01% | 591 |
|
|
2020
Q4 | $2.49M | Buy |
35,050
+6,404
| +22% | +$455K | 0.01% | 581 |
|
|
2020
Q3 | $1.08M | Sell |
28,646
-646
| -2% | -$24.2K | 0.01% | 705 |
|
|
2020
Q2 | $955K | Buy |
29,292
+7,894
| +37% | +$257K | 0.01% | 726 |
|
|
2020
Q1 | $621K | Sell |
21,398
-8,388
| -28% | -$243K | ﹤0.01% | 692 |
|
|
2019
Q4 | $1.04M | Buy |
+29,786
| New | +$1.04M | ﹤0.01% | 787 |
|